Search research articles
Contact Us
Filters
Showing results (61-70 of 123) with videos related to
Page
of 13
Sort By:
Leukemia & Lymphoma
|
October 13, 2022
Early mortality risk with non-intensive acute myeloid leukemia (AML) therapies: analysis of 1336 patients from MRC/NCRI and SWOG
Megan Othus, Ian Thomas, Xu Wang, et al.
British Journal of Haematology
|
November 19, 2015
Azacitidine with or without Entinostat for the treatment of therapy-related myeloid neoplasm: further results of the E1905 North American Leukemia Intergroup study
Thomas Prebet, Zhuoxin Sun, Rhett P Ketterling, et al.
Blood Advances
|
April 8, 2026
Quizartinib in newly diagnosed patients with FLT3-ITD-positive AML who received maintenance therapy in QuANTUM-First
Mark J Levis, Harry P Erba, Pau Montesinos, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 6, 2025
Synergistic Activity of Combined FLT3-ITD and MDM2 Inhibition With Quizartinib and Milademetan in FLT3-ITD Mutant/TP53 Wild Type Acute Myeloid Leukemias
Weiguo Zhang, Li Li, Muharrem Muftuoglu, et al.
Haematologica
|
April 6, 2023
Examining the impact of age on the prognostic value of ELN-2017 and ELN-2022 acute myeloid leukemia risk stratifications: a report from the SWOG Cancer Research Network
Christina M Termini, Anna Moseley, Megan Othus, et al.
Blood Advances
|
July 15, 2022
Disparities in trial enrollment and outcomes of Hispanic adolescent and young adult acute lymphoblastic leukemia
Lori Muffly, Jun Yin, Sawyer Jacobson, et al.
Hematological Oncology
|
April 22, 2023
A phase 1b study of venetoclax and alvocidib in patients with relapsed/refractory acute myeloid leukemia
Brian A Jonas, Jing-Zhou Hou, Gail J Roboz, et al.
Leukemia
|
March 27, 2021
Outcomes of patients with IDH1-mutant relapsed or refractory acute myeloid leukemia receiving ivosidenib who proceeded to hematopoietic stem cell transplant
Courtney D DiNardo, Eytan M Stein, Arnaud Pigneux, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 26, 2014
Prolonged administration of azacitidine with or without entinostat for myelodysplastic syndrome and acute myeloid leukemia with myelodysplasia-related changes: results of the US Leukemia Intergroup trial E1905
Thomas Prebet, Zhuoxin Sun, Maria E Figueroa, et al.
Blood Advances
|
November 2, 2022
Dasatinib/prednisone induction followed by blinatumomab/dasatinib in Ph+ acute lymphoblastic leukemia
Anjali S Advani, Anna Moseley, Kristen M O'Dwyer, et al.
Page
of 13
Search research articles
Search
Showing results (61-70 of 123) with videos related to
Sort By:
Page
of 13
Leukemia & Lymphoma
|
October 13, 2022
Early mortality risk with non-intensive acute myeloid leukemia (AML) therapies: analysis of 1336 patients from MRC/NCRI and SWOG
Megan Othus, Ian Thomas, Xu Wang, et al.
British Journal of Haematology
|
November 19, 2015
Azacitidine with or without Entinostat for the treatment of therapy-related myeloid neoplasm: further results of the E1905 North American Leukemia Intergroup study
Thomas Prebet, Zhuoxin Sun, Rhett P Ketterling, et al.
Blood Advances
|
April 8, 2026
Quizartinib in newly diagnosed patients with FLT3-ITD-positive AML who received maintenance therapy in QuANTUM-First
Mark J Levis, Harry P Erba, Pau Montesinos, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 6, 2025
Synergistic Activity of Combined FLT3-ITD and MDM2 Inhibition With Quizartinib and Milademetan in FLT3-ITD Mutant/TP53 Wild Type Acute Myeloid Leukemias
Weiguo Zhang, Li Li, Muharrem Muftuoglu, et al.
Haematologica
|
April 6, 2023
Examining the impact of age on the prognostic value of ELN-2017 and ELN-2022 acute myeloid leukemia risk stratifications: a report from the SWOG Cancer Research Network
Christina M Termini, Anna Moseley, Megan Othus, et al.
Blood Advances
|
July 15, 2022
Disparities in trial enrollment and outcomes of Hispanic adolescent and young adult acute lymphoblastic leukemia
Lori Muffly, Jun Yin, Sawyer Jacobson, et al.
Hematological Oncology
|
April 22, 2023
A phase 1b study of venetoclax and alvocidib in patients with relapsed/refractory acute myeloid leukemia
Brian A Jonas, Jing-Zhou Hou, Gail J Roboz, et al.
Leukemia
|
March 27, 2021
Outcomes of patients with IDH1-mutant relapsed or refractory acute myeloid leukemia receiving ivosidenib who proceeded to hematopoietic stem cell transplant
Courtney D DiNardo, Eytan M Stein, Arnaud Pigneux, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 26, 2014
Prolonged administration of azacitidine with or without entinostat for myelodysplastic syndrome and acute myeloid leukemia with myelodysplasia-related changes: results of the US Leukemia Intergroup trial E1905
Thomas Prebet, Zhuoxin Sun, Maria E Figueroa, et al.
Blood Advances
|
November 2, 2022
Dasatinib/prednisone induction followed by blinatumomab/dasatinib in Ph+ acute lymphoblastic leukemia
Anjali S Advani, Anna Moseley, Kristen M O'Dwyer, et al.
Page
of 13